Journal article · 2014 · Open access

Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation

Shiguo Zhu, Prasad V. Phatarpekar, Cecele J. Denman, Vladimir Senyukov, Srinivas S. Somanchi, Hoainam T. Nguyen-Jackson, Emily Margaret Mace, Alexandra F. Freeman, Stephanie S. Watowich, Jordan Scott Orange, Steven M. Holland, Dean Anthony Lee

Blood, 124(3), 403–411 · Published 3 June 2014 · DOI 10.1182/blood-2013-05-499707

Open full textView at the publisherCite this paper

In brief

“Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation” is a 2014 journal article by Shiguo Zhu and 11 co-authors, published in Blood. OpenAlex counts 87 citations as of 18 November 2026, which puts it in the top 5% of works published in 2014 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
87
Most cited in
2023 (14)
Field-weighted impact
3.32
References
50
Authors
12

Abstract

Signal transducer and activator of transcription 3 (STAT3) is considered a negative regulator of inflammation, as inhibition of STAT3 signaling enhances antitumor immunity. However, STAT3 activation is a key oncogenic pathway in natural killer (NK)-lineage large granular lymphomas, and we recently reported enhanced proliferation and function of human NK cells activated with IL-21, which signals primarily through STAT3. These IL-21-expanded NK cells also have increased NKG2D expression, which led us to focus our investigation on whether STAT3 regulates NKG2D. In this study, we show that modulation of STAT3 phosphorylation with cytokines and small-molecule inhibitors correlates with NKG2D expression on human NK cells, leading to altered NK-cell degranulation. Moreover, NKG2D expression on murine NK cells having conditional STAT3 ablation is lower than on NK cells from wild-type mice, and human NK cells carrying dominant-negative STAT3 mutations have decreased baseline NKG2D expression and blunted responses to IL-10 and IL-21. Lastly, we show binding of STAT3 to a predicted STAT3 binding site upstream of the NKG2D gene, which is enhanced by IL-10 and IL-21 and decreased by STAT3 inhibition. Taken together, these data show that NKG2D expression in NK cells is regulated at the transcriptional level by STAT3, resulting in a functional NK cell defect in patients with STAT3 mutations.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhu, S., Phatarpekar, P. V., Denman, C. J., Senyukov, V., Somanchi, S. S., Nguyen-Jackson, H. T., Mace, E. M., Freeman, A. F., Watowich, S. S., Orange, J. S., Holland, S. M., & Lee, D. A. (2014). Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation. Blood, 124(3), 403–411. https://doi.org/10.1182/blood-2013-05-499707

MLA 9

Zhu, Shiguo, et al. “Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.” Blood, vol. 124, no. 3, 2014, pp. 403–411. https://doi.org/10.1182/blood-2013-05-499707.

Chicago

Zhu, Shiguo, Prasad V. Phatarpekar, Cecele J. Denman, Vladimir Senyukov, Srinivas S. Somanchi, Hoainam T. Nguyen-Jackson, Emily Margaret Mace, et al. 2014. “Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.” Blood 124 (3): 403–411. https://doi.org/10.1182/blood-2013-05-499707.

Harvard

Zhu, S. et al. (2014) ‘Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation’, Blood, 124(3), pp. 403–411. doi:10.1182/blood-2013-05-499707.

IEEE

S. Zhu et al., “Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation,” Blood, vol. 124, no. 3, pp. 403–411, 2014, doi: 10.1182/blood-2013-05-499707.

BibTeX

@article{zhu2014transcription,
  title     = {{Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation}},
  author    = {Zhu, Shiguo and Phatarpekar, Prasad V. and Denman, Cecele J. and Senyukov, Vladimir and Somanchi, Srinivas S. and Nguyen-Jackson, Hoainam T. and Mace, Emily Margaret and Freeman, Alexandra F. and Watowich, Stephanie S. and Orange, Jordan Scott and Holland, Steven M. and Lee, Dean Anthony},
  journal   = {Blood},
  year      = {2014},
  volume    = {124},
  number    = {3},
  pages     = {403--411},
  doi       = {10.1182/blood-2013-05-499707},
  url       = {https://doi.org/10.1182/blood-2013-05-499707}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201799
201866
201988
202066
202177
202266
20231414
202477
202533
202644

Its field-weighted citation impact is 3.32: it has been cited 3.32 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction

  • NKG2D
  • STAT3
  • natural killer cells
  • transcriptional regulation
  • tyrosine phosphorylation
  • IL-21
  • IL-10
  • NK cell degranulation

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Zhu, S., Phatarpekar, P. V., Denman, C. J., Senyukov, V., Somanchi, S. S., Nguyen-Jackson, H. T., Mace, E. M., Freeman, A. F., Watowich, S. S., Orange, J. S., Holland, S. M., & Lee, D. A. (2014). Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation. Blood, 124(3), 403–411. https://doi.org/10.1182/blood-2013-05-499707

How many times has this paper been cited?

87 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Shiguo Zhu, Prasad V. Phatarpekar, Cecele J. Denman, Vladimir Senyukov, Srinivas S. Somanchi, Hoainam T. Nguyen-Jackson, Emily Margaret Mace, Alexandra F. Freeman, Stephanie S. Watowich, Jordan Scott Orange, Steven M. Holland, Dean Anthony Lee.

What is the DOI of this paper?

10.1182/blood-2013-05-499707, permanently at https://doi.org/10.1182/blood-2013-05-499707. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.